ArticleJACC. Case reports2025
Recurrent Cancer-Associated Nonbacterial Endocarditis Presenting With Systemic Embolic Complications.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNonbacterial thrombotic endocarditis (NBTE) is a rare complication of malignancy, often leading to systemic embolization. CASE SUMMARY: A 52-year-old woman presented with embolic ischemic stroke, multiple systemic infarctions, a pelvic mass, and aortic valve vegetations. The pelvic mass was completely resected and was subsequently diagnosed as ovarian clear cell carcinoma. The valvular vegetations were identified as NBTE. Despite ongoing anticoagulation therapy with edoxaban, she developed recurrent vegetations on the mitral valves in association with cancer recurrence. Based on the patient's preference, anticoagulation therapy with edoxaban was continued. She later experienced an upper limb arterial embolism and died after 3 months. DISCUSSION: This case highlights the diagnostic and therapeutic challenges of NBTE in cancer patients, particularly in the context of temporally distinct recurrences involving different cardiac valves despite appropriate oncologic and anticoagulant therapy. TAKE-HOME MESSAGE: Vigilant valvular monitoring and individualized anticoagulation strategies are necessary when managing patients with hypercoagulable malignancies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.